Efficacy of cefepime therapy for Enterobacter bacteraemia, with special emphasis on febrile neutropenic patients

被引：1
|
作者：
Lee, Jeong-A [1 ]
Kang, Cheol-In [1 ]
Joung, Mi-Kyong [1 ]
Moon, Soo-Youn [1 ]
Chung, Doo Ryeon [1 ]
Ko, Kwan Soo [2 ]
Peck, Kyong Ran [1 ]
Song, Jae-Hoon [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea
来源：
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES | 2010年 / 42卷 / 6-7期
关键词：
BETA-LACTAMASE; INFECTIONS; TESTS;
D O I：
10.3109/00365541003621528
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：557 / 559
页数：3
相关论文
共 50 条
  • [21] Empirical antifungal therapy in treating febrile neutropenic patients
    Wingard, JR
    CLINICAL INFECTIOUS DISEASES, 2004, 39 : S38 - S43
  • [22] Comparison between imipenem/cilistatin (I) and cefepime (C) as initial therapy for febrile neutropenic cancer patients (pts) requiring hospitalization
    Raad, II
    Escalante, C
    Hachem, RY
    Hanna, H
    Afif, C
    Boktour, M
    Whimbey, EE
    Kontoyiannis, DP
    Jacobson, K
    Bodey, GP
    Rolston, KV
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1106 - 1106
  • [23] IMIPENEM CILASTATIN AS INITIAL THERAPY FOR FEBRILE NEUTROPENIC PATIENTS
    LIANG, R
    YUNG, R
    CHAU, PY
    CHAN, TK
    LAM, WK
    SO, SY
    TODD, D
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (05) : 765 - 770
  • [24] Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies
    Chong, Yong
    Yakushiji, Hiroko
    Ito, Yoshikiyo
    Kamimura, Tomohiko
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E171 - E175
  • [25] Low dose cefepime as empirical monotherapy for febrile episodes in short duration neutropenic patients.
    Muñoz, MA
    Climent, MA
    Gaspar, C
    Soriano, V
    Lavernia, J
    Torres, A
    Maiquez, J
    Guillem, V
    ANNALS OF ONCOLOGY, 2000, 11 : 150 - 150
  • [26] Cefepime versus ceftazidime as empiric therapy for fever in neutropenic patients with cancer
    Chandrasekar, PH
    Arnow, PM
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (09) : 989 - 995
  • [27] EFFICACY OF AMIKACIN AND TICARCILLIN AS EMPIRIC THERAPY IN FEBRILE NEUTROPENIC CHILDREN WITH CANCER
    FADEN, HS
    DESHPANDE, GN
    GROSSI, M
    SURGALLA, M
    ETTINGER, LJ
    FREEMAN, AI
    MEDICAL AND PEDIATRIC ONCOLOGY, 1981, 9 (05): : 501 - 509
  • [28] EFFICACY OF AMIKACIN AND TICARCILLIN AS EMPIRIC THERAPY IN FEBRILE NEUTROPENIC CHILDREN WITH CANCER
    DESHPANDE, G
    FADEN, H
    SURGALLA, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 333 - 333
  • [29] Cefozopran, meropenem, or imipenem-cilastatin compared with cefepime as empirical therapy in febrile neutropenic adult patients: A multicenter prospective randomized trial
    Nakane, Takahiko
    Tamura, Kazuo
    Hino, Masayuki
    Tamaki, Toshiharu
    Yoshida, Isao
    Fukushima, Toshihiro
    Tatsumi, Youichi
    Nakagawa, Yasuaki
    Hatanaka, Kazuo
    Takahashi, Tsutomu
    Akiyama, Nobu
    Tanimoto, Mitsune
    Ohyashiki, Kazuma
    Urabe, Akio
    Masaoka, Toru
    Kanamaru, Akihisa
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2015, 21 (1-2) : 16 - 22
  • [30] High cefepime plasma concentrations and toxic encephalopathy in febrile neutropenic patients with mild impairment of renal function
    Lamoth, F.
    Buclin, T.
    Pascual, A.
    Vora, S.
    Bolay, S.
    Decosterd, L. A.
    Calandra, T.
    Marchetti, O.
    SWISS MEDICAL WEEKLY, 2009, 139 (9-10) : 32S - 32S
12345